| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |